Indefinite Delivery Contract HHSN268201200004I

Ended Awarded Last action

Contract number
HHSN268201200004I
Awardee
Awarding agency
Task orders
6 $3,605,124 obligated

Award facts

Combined order value
$3,605,124 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 70% used
$5,147,636.00
Maximum order
$5,147,636.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Basic Research
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

About this IDV

The National Heart, Lung, and Blood Institute (NHLBI) awarded a single-award Indefinite Delivery Contract valued at $5.15 million to The Children's Hospital of Philadelphia (CHOP) Research Institute for the Gene Therapy Resource Program (GTRP) Adeno-Associated Virus (AAV) Vector Production Core Laboratory. The contract, effective from June 15, 2012 through June 14, 2017, supports critical infrastructure for gene therapy research by providing AAV vector production services and related laboratory activities. This civilian contract, utilizing open competition procurement with no set-aside designation, leverages CHOP's specialized expertise in genetic disorder research and biomedical innovation to advance the National Eye Institute's gene therapy initiatives. The primary place of performance is located in Philadelphia, Pennsylvania, with secondary operations in Bethesda, Maryland.

Six delivery orders were issued under this IDV, collectively obligating approximately $3.6 million across multiple fiscal years (2012–2016). The delivery orders encompassed core laboratory activities, vector production services, and research support functions, with pricing structures alternating between cost-plus-fixed-fee and cost-no-fee arrangements. Notable task orders included Task Order 1 ($369,057), Task Order 2 ($773,166), Task Order 3 ($598,673), and subsequent annual performance periods supporting the NEI and designated principal investigators. CHOP's execution of these delivery orders demonstrated sustained capacity to manufacture and provide specialized gene therapy vectors essential for translational research, contributing directly to advancing precision medicine approaches for inherited eye diseases and other genetic conditions through federally funded research infrastructure.

Task orders

Transactions

Action Obligated Date
Other Administrative Action 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award Gtrp AAV vector production core lab $0

Quick answers

Who was awarded contract HHSN268201200004I?

HHSN268201200004I was awarded to The Children's Hospital Of Philadelphia by National Heart Lung and Blood Institute (National Institutes of Health) on June 15, 2012.

How much is contract HHSN268201200004I worth?

Orders under HHSN268201200004I have obligated $3,605,124. HHSN268201200004I's own ceiling is $5,147,636. A single order can be worth up to $5,147,636.

How many orders have been placed under contract HHSN268201200004I?

6 orders have been placed under HHSN268201200004I, the latest on June 1, 2016.

Who can order from contract HHSN268201200004I?

HHSN268201200004I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSN268201200004I competed?

The extent of competition for HHSN268201200004I was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV